The Iron Tug-of-War between Bacterial Siderophores and Innate Immunity

Journal of Innate Immunity

Volumn 11, Issue 3, 2019, Pages 249-262

  Golonka, Rachel ^a   Yeoh, Beng San ^b   Vijay Kumar, Matam ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Dihydroxybenzoic acid; Enterochelin; NGAL; Siderocalin

Indexed keywords

2,5 DIHYDROXBENZOIC ACID; ANTIBIOTIC AGENT; ANTICALIN DERIVATIVE; BENZOIC ACID DERIVATIVE; BINDING PROTEIN; CATECHOLAMINE; CATECHOLATE SIDEROPHORE DERIVATIVE; CYCLIC DIGUANYLATE MONOPHOSPHATE; DRUG CARRIER; FERROPORTIN; HEME BINDING PROTEIN; HEPCIDIN; IRON; IRON BINDING PROTEIN; LIPOCALIN; MIXED STEALTH SIDEROPHORE DERIVATIVE; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; PHOSPHORIC ACID DERIVATIVE; REACTIVE OXYGEN METABOLITE; RIBONUCLEOTIDE REDUCTASE; SIDEROMYCIN DERIVATIVE; SIDEROPHORE; SULFUR; TRIHYDROXAMATE SIDEROPHORE DERIVATIVE; UNCLASSIFIED DRUG; XENOSIDEROPHORE DERIVATIVE; BIS(3',5')-CYCLIC DIGUANYLIC ACID; CYCLIC GMP; FERROUS ION; PEPTIDE; SIDEROMYCINS;

BACTERIAL GROWTH; BACTERIAL SURVIVAL; BINDING AFFINITY; DNA SYNTHESIS; DRUG DELIVERY SYSTEM; ENZYME ACTIVITY; HEME SYNTHESIS; HORMONE ACTION; HOST PATHOGEN INTERACTION; HUMAN; HYPOFERREMIA; INFLAMMATION; INNATE IMMUNITY; IRON CHELATION; IRON OVERLOAD; MICROBIAL ACTIVITY; NONHUMAN; OXYGEN TRANSPORT; PRIORITY JOURNAL; PROTEIN DEGRADATION; REGULATORY MECHANISM; REVIEW; CHEMISTRY; METABOLISM; NEUTROPHIL; PHYSIOLOGY;

CYCLIC GMP; FERROUS COMPOUNDS; HOST MICROBIAL INTERACTIONS; HUMANS; IMMUNITY, INNATE; INFLAMMATION; IRON; LIPOCALIN-2; NEUTROPHILS; PEPTIDES; REACTIVE OXYGEN SPECIES; SIDEROPHORES;

EID: 85059608156     PISSN: 1662811X     EISSN: 16628128     Source Type: Journal    
DOI: 10.1159/000494627     Document Type: Review

References (96)

1. Caza M, Kronstad JW. Shared and distinct mechanisms of iron acquisition by bacterial and fungal pathogens of humans. Front Cell Infect Microbiol. 2013 Nov; 3: 80.
2. Pantopoulos K, Porwal SK, Tartakoff A, Devireddy L. Mechanisms of mammalian iron homeostasis. Biochemistry. 2012 Jul; 51(29): 5705-24.
3. Hider RC, Kong X. Chemistry and biology of siderophores. Nat Prod Rep. 2010 May; 27(5): 637-57.
4. Pandey A, Bringel F, Meyer JM. Iron requirement and search for siderophores in lactic acid bacteria. Appl Microbiol Biotechnol. 1994; 40(5): 735-9.
5. Posey JE, Gherardini FC. Lack of a role for iron in the Lyme disease pathogen. Science. 2000 Jun; 288(5471): 1651-3.
6. Gozzelino R, Arosio P. Iron Homeostasis in Health and Disease. Int J Mol Sci. 2016 Jan; 17(1): 17.
7. Zhang C. Essential functions of iron-requiring proteins in DNA replication, repair and cell cycle control. Protein Cell. 2014 Oct; 5(10): 750-60.
8. Ilbert M, Bonnefoy V. Insight into the evolution of the iron oxidation pathways. Biochim Biophys Acta. 2013 Feb; 1827(2): 161-75.
9. Andrews SC, Robinson AK, Rodríguez-Quiñones F. Bacterial iron homeostasis. FEMS Microbiol Rev. 2003 Jun; 27(2-3): 215-37.
10. Ganz T, Nemeth E. Iron homeostasis in host defence and inflammation. Nat Rev Immunol. 2015 Aug; 15(8): 500-10.
11. Weinberg ED. Nutritional immunity. Host's attempt to withold iron from microbial invaders. JAMA. 1975 Jan; 231(1): 39-41.
12. Krewulak KD, Vogel HJ. Structural biology of bacterial iron uptake. Biochim Biophys Acta. 2008 Sep; 1778(9): 1781-804.
13. Wilson BR, Bogdan AR, Miyazawa M, Hashimoto K, Tsuji Y. Siderophores in Iron Metabolism: From Mechanism to Therapy Potential. Trends Mol Med. 2016 Dec; 22(12): 1077-90.
14. Li N, Zhang C, Li B, Liu X, Huang Y, Xu S, et al. Unique iron coordination in iron-chelating molecule vibriobactin helps Vibrio cholerae evade mammalian siderocalin-mediated immune response. J Biol Chem. 2012 Mar; 287(12): 8912-9.
15. Allred BE, Correnti C, Clifton MC, Strong RK, Raymond KN. Siderocalin outwits the coordination chemistry of vibriobactin, a siderophore of Vibrio cholerae. ACS Chem Biol. 2013 Sep; 8(9): 1882-7.
16. Miethke M, Skerra A. Neutrophil gelatinaseassociated lipocalin expresses antimicrobial activity by interfering with L-norepinephrine-mediated bacterial iron acquisition. Antimicrob Agents Chemother. 2010 Apr; 54(4): 1580-9.
17. Devireddy LR, Hart DO, Goetz DH, Green MR. A mammalian siderophore synthesized by an enzyme with a bacterial homolog involved in enterobactin production. Cell. 2010 Jun; 141(6): 1006-17.
18. Nemeth E, Rivera S, Gabayan V, Keller C, Taudorf S, Pedersen BK, et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest. 2004 May; 113(9): 1271-6.
19. Rishi G, Wallace DF, Subramaniam VN. Hepcidin: regulation of the master iron regulator. Biosci Rep. 2015 Mar; 35(3): 35.
20. Ganz T, Nemeth E. Hepcidin and iron homeostasis. Biochim Biophys Acta. 2012 Sep; 1823(9): 1434-43.
21. Xiao X, Yeoh BS, Saha P, Olvera RA, Singh V, Vijay-Kumar M. Lipocalin 2 alleviates iron toxicity by facilitating hypoferremia of inflammation and limiting catalytic iron generation. Biometals. 2016 Jun; 29(3): 451-65.
22. Srinivasan G, Aitken JD, Zhang B, Carvalho FA, Chassaing B, Shashidharamurthy R, et al. Lipocalin 2 deficiency dysregulates iron homeostasis and exacerbates endotoxin-induced sepsis. J Immunol. 2012 Aug; 189(4): 1911-9.
23. Kim DK, Jeong JH, Lee JM, Kim KS, Park SH, Kim YD, et al. Inverse agonist of estrogen-related receptor γ controls Salmonella typhimurium infection by modulating host iron homeostasis. Nat Med. 2014 Apr; 20(4): 419-24.
24. Nairz M, Fritsche G, Brunner P, Talasz H, Hantke K, Weiss G. Interferon-gamma limits the availability of iron for intramacrophage Salmonella typhimurium. Eur J Immunol. 2008 Jul; 38(7): 1923-36.
25. Warszawska JM, Gawish R, Sharif O, Sigel S, Doninger B, Lakovits K, et al. Lipocalin 2 deactivates macrophages and worsens pneumococcal pneumonia outcomes. J Clin Invest. 2013 Aug; 123(8): 3363-72.
26. Rosa L, Cutone A, Lepanto MS, Paesano R, Valenti P. Lactoferrin: A Natural Glycoprotein Involved in Iron and Inflammatory Homeostasis. Int J Mol Sci. 2017 Sep; 18(9): 18.
27. Jiang R, Lopez V, Kelleher SL, Lönnerdal B. Apo-and holo-lactoferrin are both internalized by lactoferrin receptor via clathrin-mediated endocytosis but differentially affect ERKsignaling and cell proliferation in Caco-2 cells. J Cell Physiol. 2011 Nov; 226(11): 3022-31.
28. Frawley ER, Fang FC. The ins and outs of bacterial iron metabolism. Mol Microbiol. 2014 Aug; 93(4): 609-16.
29. Kim J, Park C, Imlay JA, Park W. Lineagespecific SoxR-mediated Regulation of an Endoribonuclease Protects Non-enteric Bacteria from Redox-active Compounds. J Biol Chem. 2017 Jan; 292(1): 121-33.
30. Miller HK, Auerbuch V. Bacterial iron-sulfur cluster sensors in mammalian pathogens. Metallomics. 2015 Jun; 7(6): 943-56.
31. Rodionov DA, Dubchak IL, Arkin AP, Alm EJ, Gelfand MS. Dissimilatory metabolism of nitrogen oxides in bacteria: comparative reconstruction of transcriptional networks. PLOS Comput Biol. 2005 Oct; 1(5):e55.
32. Tucker NP, D'autréaux B, Spiro S, Dixon R. Mechanism of transcriptional regulation by the Escherichia coli nitric oxide sensor NorR. Biochem Soc Trans. 2006 Feb; 34(Pt 1): 191-4.
33. Tucker NP, Hicks MG, Clarke TA, Crack JC, Chandra G, Le Brun NE, et al. The transcriptional repressor protein NsrR senses nitric oxide directly via a [2Fe-2S] cluster. PLoS One. 2008; 3(11):e3623.
34. Pasqua M, Visaggio D, Lo Sciuto A, Genah S, Banin E, Visca P, et al. Ferric Uptake Regulator Fur Is Conditionally Essential in Pseudomonas aeruginosa. J Bacteriol. 2017 Oct; 199(22): 199.
35. Troxell B, Hassan HM. Transcriptional regulation by Ferric Uptake Regulator (Fur) in pathogenic bacteria. Front Cell Infect Microbiol. 2013 Oct; 3: 59.
36. Xiao X, Yeoh BS, Vijay-Kumar M. Lipocalin 2: An Emerging Player in Iron Homeostasis and Inflammation. Annu Rev Nutr. 2017 Aug; 37(1): 103-30.
37. Bachman MA, Miller VL, Weiser JN. Mucosal lipocalin 2 has pro-inflammatory and ironsequestering effects in response to bacterial enterobactin. PLoS Pathog. 2009 Oct; 5(10): e1000622.
38. Flo TH, Smith KD, Sato S, Rodriguez DJ, Holmes MA, Strong RK, et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature. 2004 Dec; 432(7019): 917-21.
39. Goodwin JF, Whitten CF. Chelation of Ferrous Sulphate Solutions by Desferrioxamine B. Nature. 1965 Jan; 205(4968): 281-3.
40. Poggiali E, Cassinerio E, Zanaboni L, Cappellini MD. An update on iron chelation therapy. Blood Transfus. 2012 Oct; 10(4): 411-22.
41. Ratledge C, Ewing M. The occurrence of carboxymycobactin, the siderophore of pathogenic mycobacteria, as a second extracellular siderophore in Mycobacterium smegmatis. Microbiology. 1996 Aug; 142(Pt 8): 2207-12.
42. Holmes MA, Paulsene W, Jide X, Ratledge C, Strong RK. Siderocalin (Lcn 2) also binds carboxymycobactins, potentially defending against mycobacterial infections through iron sequestration. Structure. 2005 Jan; 13(1): 29-41.
43. Bailey DC, Alexander E, Rice MR, Drake EJ, Mydy LS, Aldrich CC, et al. Structural and functional delineation of aerobactin biosynthesis in hypervirulent Klebsiella pneumoniae. J Biol Chem. 2018 May; 293(20): 7841-52.
44. Perry RD, Fetherston JD. Yersiniabactin iron uptake: mechanisms and role in Yersinia pestis pathogenesis. Microbes Infect. 2011 Sep; 13(10): 808-17.
45. Fischbach MA, Lin H, Zhou L, Yu Y, Abergel RJ, Liu DR, et al. The pathogen-associated iroA gene cluster mediates bacterial evasion of lipocalin 2. Proc Natl Acad Sci USA. 2006 Oct; 103(44): 16502-7.
46. Cuív PO, Keogh D, Clarke P, O'Connell M. FoxB of Pseudomonas aeruginosa functions in the utilization of the xenosiderophores ferrichrome, ferrioxamine B, and schizokinen: evidence for transport redundancy at the inner membrane. J Bacteriol. 2007 Jan; 189(1): 284-7.
47. Ahmed E, Holmström SJ. Siderophores in environmental research: roles and applications. Microb Biotechnol. 2014 May; 7(3): 196-208.
48. Liu Z, Reba S, Chen WD, Porwal SK, Boom WH, Petersen RB, et al. Regulation of mammalian siderophore 2,5-DHBA in the innate immune response to infection. J Exp Med. 2014 Jun; 211(6): 1197-213.
49. Correnti C, Richardson V, Sia AK, Bandaranayake AD, Ruiz M, Suryo Rahmanto Y, et al. Siderocalin/Lcn2/NGAL/24p3 does not drive apoptosis through gentisic acid mediated iron withdrawal in hematopoietic cell lines. PLoS One. 2012; 7(8):e43696.
50. Liu Z, Ciocea A, Devireddy L. Endogenous siderophore 2,5-dihydroxybenzoic acid deficiency promotes anemia and splenic iron overload in mice. Mol Cell Biol. 2014 Jul; 34(13): 2533-46.
51. Song E, Ramos SV, Huang X, Liu Y, Botta A, Sung HK, et al. Holo-lipocalin-2-derived siderophores increase mitochondrial ROS and impair oxidative phosphorylation in rat cardiomyocytes. Proc Natl Acad Sci USA. 2018 Feb; 115(7): 1576-81.
52. Correnti C, Strong RK. Mammalian siderophores, siderophore-binding lipocalins, and the labile iron pool. J Biol Chem. 2012 Apr; 287(17): 13524-31.
53. Flower DR, North AC, Sansom CE. The lipocalin protein family: structural and sequence overview. Biochim Biophys Acta. 2000 Oct; 1482(1-2): 9-24.
54. Kjeldsen L, Johnsen AH, Sengeløv H, Borregaard N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem. 1993 May; 268(14): 10425-32.
55. Triebel S, Bläser J, Reinke H, Tschesche H. A 25. kDa alpha 2-microglobulin-related protein is a component of the 125 kDa form of human gelatinase. FEBS Lett. 1992 Dec; 314(3): 386-8.
56. Goetz DH, Holmes MA, Borregaard N, Bluhm ME, Raymond KN, Strong RK. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol Cell. 2002 Nov; 10(5): 1033-43.
57. Chassaing B, Srinivasan G, Delgado MA, Young AN, Gewirtz AT, Vijay-Kumar M. Fecal lipocalin 2, a sensitive and broadly dynamic non-invasive biomarker for intestinal inflammation. PLoS One. 2012; 7(9):e44328.
58. Peek ME, Bhatnagar A, McCarty NA, Zughaier SM. Pyoverdine, the Major Siderophore in Pseudomonas aeruginosa, Evades NGAL Recognition. Interdiscip Perspect Infect Dis. 2012; 2012: 843509.
59. Forster CS, Johnson K, Patel V, Wax R, Rodig N, Barasch J, et al. Urinary NGAL deficiency in recurrent urinary tract infections. Pediatr Nephrol. 2017 Jun; 32(6): 1077-80.
60. Liu Z, Petersen R, Devireddy L. Impaired neutrophil function in 24p3 null mice contributes to enhanced susceptibility to bacterial infections. J Immunol. 2013 May; 190(9): 4692-706.
61. Abergel RJ, Moore EG, Strong RK, Raymond KN. Microbial evasion of the immune system: structural modifications of enterobactin impair siderocalin recognition. J Am Chem Soc. 2006 Aug; 128(34): 10998-9.
62. Fluckinger M, Haas H, Merschak P, Glasgow BJ, Redl B. Human tear lipocalin exhibits antimicrobial activity by scavenging microbial siderophores. Antimicrob Agents Chemother. 2004 Sep; 48(9): 3367-72.
63. Nelson AL, Ratner AJ, Barasch J, Weiser JN. Interleukin-8 secretion in response to aferric enterobactin is potentiated by siderocalin. Infect Immun. 2007 Jun; 75(6): 3160-8.
64. Choi EY, Kim EC, Oh HM, Kim S, Lee HJ, Cho EY, et al. Iron chelator triggers inflammatory signals in human intestinal epithelial cells: involvement of p38 and extracellular signal-regulated kinase signaling pathways. J Immunol. 2004 Jun; 172(11): 7069-77.
65. Holden VI, Lenio S, Kuick R, Ramakrishnan SK, Shah YM, Bachman MA. Bacterial siderophores that evade or overwhelm lipocalin 2 induce hypoxia inducible factor 1α and proinflammatory cytokine secretion in cultured respiratory epithelial cells. Infect Immun. 2014 Sep; 82(9): 3826-36.
66. Hartmann H, Eltzschig HK, Wurz H, Hantke K, Rakin A, Yazdi AS, et al. Hypoxia-independent activation of HIF-1 by enterobacteriaceae and their siderophores. Gastroenterology. 2008 Mar; 134(3): 756-67.
67. Peyssonnaux C, Datta V, Cramer T, Doedens A, Theodorakis EA, Gallo RL, et al. HIF-1alpha expression regulates the bactericidal capacity of phagocytes. J Clin Invest. 2005 Jul; 115(7): 1806-15.
68. Holden VI, Wright MS, Houle S, Collingwood A, Dozois CM, Adams MD, et al. Iron Acquisition and Siderophore Release by Carbapenem-Resistant Sequence Type 258 Klebsiella pneumoniae. MSphere. 2018 Apr; 3(2): 3.
69. Hengge R. Trigger phosphodiesterases as a novel class of c-di-GMP effector proteins. Philos Trans R Soc Lond B Biol Sci. 2016 Nov; 371(1707): 371.
70. Li W, Cui T, Hu L, Wang Z, Li Z, He ZG. Cyclic diguanylate monophosphate directly binds to human siderocalin and inhibits its antibacterial activity. Nat Commun. 2015 Sep; 6(1): 8330.
71. Latasa C, Echeverz M, García B, Gil C, García-Ona E, Burgui S, et al. Evaluation of a Salmonella Strain Lacking the Secondary Messenger C-di-GMP and RpoS as a Live Oral Vaccine. PLoS One. 2016 Aug; 11(8):e0161216.
72. Saha P, Yeoh BS, Olvera RA, Xiao X, Singh V, Awasthi D, et al. Bacterial Siderophores Hijack Neutrophil Functions. J Immunol. 2017 Jun; 198(11): 4293-303.
73. Singh V, Yeoh BS, Xiao X, Kumar M, Bachman M, Borregaard N, et al. Interplay between enterobactin, myeloperoxidase and lipocalin 2. regulates E. coli survival in the inflamed gut. Nat Commun. 2015 May; 6(1): 7113.
74. Coker MS, Forbes LV, Plowman-Holmes M, Murdoch DR, Winterbourn CC, Kettle AJ. Interactions of staphyloxanthin and enterobactin with myeloperoxidase and reactive chlorine species. Arch Biochem Biophys. 2018 May; 646: 80-9.
75. Peralta DR, Adler C, Corbalán NS, Paz García EC, Pomares MF, Vincent PA. Enterobactin as Part of the Oxidative Stress Response Repertoire. PLoS One. 2016 Jun; 11(6):e0157799.
76. Adler C, Corbalan NS, Peralta DR, Pomares MF, de Cristóbal RE, Vincent PA. The alternative role of enterobactin as an oxidative stress protector allows Escherichia coli colony development. PLoS One. 2014 Jan; 9(1): e84734.
77. Sørensen OE, Borregaard N. Neutrophil extracellular traps\-The dark side of neutrophils. J Clin Invest. 2016 May; 126(5): 1612-20.
78. Völlger L, Akong-Moore K, Cox L, Goldmann O, Wang Y, Schäfer ST, et al. Iron-chelating agent desferrioxamine stimulates formation of neutrophil extracellular traps (NETs) in human blood-derived neutrophils. Biosci Rep. 2016 May; 36(3): 36.
79. Ijiri M, Fujiya M, Konishi H, Tanaka H, Ueno N, Kashima S, et al. Ferrichrome identified from Lactobacillus casei ATCC334 induces apoptosis through its iron-binding site in gastric cancer cells. Tumour Biol. 2017 Jun; 39(6): 1010428317711311.
80. Konishi H, Fujiya M, Tanaka H, Ueno N, Moriichi K, Sasajima J, et al. Probiotic-derived ferrichrome inhibits colon cancer progression via JNK-mediated apoptosis. Nat Commun. 2016 Aug; 7: 12365.
81. Mike LA, Smith SN, Sumner CA, Eaton KA, Mobley HL. Siderophore vaccine conjugates protect against uropathogenic Escherichia coli urinary tract infection. Proc Natl Acad Sci USA. 2016 Nov; 113(47): 13468-73.
82. Mobarra N, Shanaki M, Ehteram H, Nasiri H, Sahmani M, Saeidi M, et al. A Review on Iron Chelators in Treatment of Iron Overload Syndromes. Int J Hematol Oncol Stem Cell Res. 2016 Oct; 10(4): 239-47.
83. Scaldaferri F, Gerardi V, Mangiola F, Lopetuso LR, Pizzoferrato M, Petito V, et al. Role and mechanisms of action of Escherichia coli Nissle 1917 in the maintenance of remission in ulcerative colitis patients: an update. World J Gastroenterol. 2016 Jun; 22(24): 5505-11.
84. Chitambar CR. Gallium and its competing roles with iron in biological systems. Biochim Biophys Acta. 2016 Aug; 1863(8): 2044-53.
85. Braun V, Pramanik A, Gwinner T, Köberle M, Bohn E. Sideromycins: tools and antibiotics. Biometals. 2009 Feb; 22(1): 3-13.
86. Behnsen J, Raffatellu M. Siderophores: More than Stealing Iron. MBio. 2016 Nov; 7(6): 7.
87. Johnstone TC, Nolan EM. Beyond iron: nonclassical biological functions of bacterial siderophores. Dalton Trans. 2015 Apr; 44(14): 6320-39.
88. Allred BE, Rupert PB, Gauny SS, An DD, Ralston CY, Sturzbecher-Hoehne M, et al. Siderocalin-mediated recognition, sensitization, and cellular uptake of actinides. Proc Natl Acad Sci USA. 2015 Aug; 112(33): 10342-7.
89. Captain I, Deblonde GJ, Rupert PB, An DD, Illy MC, Rostan E, et al. Engineered Recognition of Tetravalent Zirconium and Thorium by Chelator-Protein Systems: Toward Flexible Radiotherapy and Imaging Platforms. Inorg Chem. 2016 Nov; 55(22): 11930-6.
90. Barasch J, Hollmen M, Deng R, Hod EA, Rupert PB, Abergel RJ, et al. Disposal of iron by a mutant form of lipocalin 2. Nat Commun. 2016 Oct; 7: 12973.
91. Sassone-Corsi M, Chairatana P, Zheng T, Perez-Lopez A, Edwards RA, George MD, et al. Siderophore-based immunization strategy to inhibit growth of enteric pathogens. Proc Natl Acad Sci USA. 2016 Nov; 113(47): 13462-7.
92. Rothe C, Skerra A. Anticalin® Proteins as Therapeutic Agents in Human Diseases. Bio-Drugs. 2018 Jun; 32(3): 233-43.
93. Richter A, Eggenstein E, Skerra A. Anticalins: exploiting a non-Ig scaffold with hypervariable loops for the engineering of binding proteins. FEBS Lett. 2014 Jan; 588(2): 213-8.
94. Schönfeld D, Matschiner G, Chatwell L, Trentmann S, Gille H, Hülsmeyer M, et al. An engineered lipocalin specific for CTLA-4 reveals a combining site with structural and conformational features similar to antibodies. Proc Natl Acad Sci USA. 2009 May; 106(20): 8198-203.
95. Richter A, Skerra A. Anticalins directed against vascular endothelial growth factor receptor 3 (VEGFR-3) with picomolar affinities show potential for medical therapy and in vivo imaging. Biol Chem. 2017 Jan; 398(1): 39-55.
96. Rauth S, Hinz D, Börger M, Uhrig M, Mayhaus M, Riemenschneider M, et al. High-affinity Anticalins with aggregation-blocking activity directed against the Alzheimer β-amyloid peptide. Biochem J. 2016 Jun; 473(11): 1563-78.